A. Ginsburg and H. K. Schachman. Studies on the enzymatic breakdown of proteins. I. Action of chymotrypsin on insulin. J. Biol. Chem.
R. J. Schilling and A. K. Mitra. Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm. Res.
V. H. L. Lee, and A. Yamamoto. Penetration and enzymatic barriers to peptide and protein absorption. Adv. Drug Delivery Rev.
M. Kidron, H. Bar-On, E. M. Berry and E. Ziv. The absorption of insulin from various regions of the rat intestine. Life Sci.
S. Fujii, T. Yokoyama, K. Ikegaya, F. Sato and N. Yokoo. Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogs. J. Pharm. Pharmacol.
C. Weingarten, A. Moufti, J. Delattre, F. Puisieux and P. Couvreur. Protection of insulin from enzymatic degradation by its association to liposomes. Int. J. Pharm.
M. Shichiri, Y. Shimizu, Y. Yoshida, R. Kawamori, M. Fukuchi, Y. Shigeta and H. Abe. Enteral absorption of water-in-oil-in water insulin emulsions in rabbits. Diabetologia
S. Muranishi, A. Sakai, K. Yamada, M. Murakami, K. Takada and Y. Kiso. Lipophilic peptides: Synthesis of lauroyl thyrotropin-releasing hormone and its biological activity. Pharm. Res.
T. Tenma, E. Yodoya, S. Tashima, T. Fujita, M. Murakami, A. Yamamoto and S. Muranishi. Development of new lipophilic derivatives of tetragastrin: Physicochemical characteristics and intestinal absorption of acyltetragastrin derivatives in rats. Pharm. Res.
M. Hashimoto, K. Takada, Y. Kiso and S. Muranishi. Synthesis of palmitoyl derivatives of insulin and their biological activities. Pharm. Res.
K. Yamada, M. Murakami, A. Yamamoto, K. Takada and S. Muranishi. Improvement of intestinal absorption of thyrotropin-releasing hormone by chemical modification with lauric acid. J. Pharm. Pharmacol.
M. Hashizume, T. Douen, M. Murakami, A. Yamamoto, K. Takada and S. Muranishi. Improvement of large intestinal absorption of insulin by chemical modification with palmitic acid in rats. J. Pharm. Pharmacol.
D. G. Lindsay and S. Shall. Acetoacetylation of insulin. Biochem. J.
H. Zahn, D. Brandenburg and H.-G. Gattner. Molecular basis of insulin action: Contributions of chemical modifications and synthetic approaches. Diabetes
K. Takada and Y. Ushirogawa. Effect of pH, dietary proteins and trypsin inhibitors on the hydrolytic rate of human granulocyte colony-stimulating factor (G-CSF) by rat digestive enzymes. J. Pharmacobio-Dyn.
A. Yamamoto, E. Hayakawa and V. H. L. Lee. Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: Implications in peptide delivery from nonoral routes. Life Sci.
M. Morishita, I. Morishita, K. Takayama, Y. Machida and T. Nagai. Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation. Int. J. Pharm.
I. Morishita, M. Morishita, K. Takayama, Y. Machida and T. Nagai. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int. J. Pharm.
M. J. Ettinger and S. N. Timasheff. Optical activity of insulin. I. On the nature of the circular dichroism bands. Biochemistry
J. Goldman and F. H. Carpenter. Zinc binding, circular dichroism, and equilibrium sedimentation studies on insulin (bovine) and several of its derivatives. Biochemistry
T. L. Blundell, J. F. Cutfield, S. M. Cutfield, E. J. Dodson, G. G. Dodson, D. C. Hodgkin and D. A. Mercola. Three-dimensional atomic structure of insulin and its relationship to activity. Diabetes
F-y. Liu, D. O. Kildsig and A. K. Mitra. Insulin aggregation in aqueous media and its effect on alpha-chymotrypsin-mediated proteolytic degradation. Pharm. Res.
Y. Li, Z. Shao and A. K. Mitra. Dissociation of insulin oligomers by bile salt micelles and its effect on α-chymotrypsin-mediated proteolytic degradation. Pharm. Res.
Z. Shao, Y. Li, R. Krishnamoorthy, T. Chermak and A. K. Mitra. Differential effects of anionic, cationic, nonionic, and physiologic surfactants on the dissociation, α-chymotryptic degradation, and enteral absorption of insulin hexamers. Pharm. Res.
J. Brange, U. Ribel, J. F. Hansen, G. Dodson, M. T. Hansen, S. Havelund, S. G. Melberg, F. Norris, K. Norris, L. Snel, A. R. Sørensen and H. O. Voigt. Monomeric insulins obtained by protein engineering and their medical implications. Nature
E. L. Smith, R. L. Hill and A. Borman. Activity of insulin degraded by leucine aminopeptidase. Biochim. Biophys. Acta
R. A. Roth. Bacitracin: An inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. Biochem. Biophys. Res. Commun.
R. E. Stratford, Jr. and V. H. L. Lee. Aminopeptidase activity in homogenates of various absorptive mucosae in the albino rabbit: Implications in peptide delivery. Int. J. Pharm.
P. Kopečková, K. Ikesue, L. Fornŭsek and J. Kopeček. Cleavage of peptide bonds by guinea pig brush border membrane enzymes. Proc. Int. Symp. Control. Rel. Bioact. Mat.